InvestorsHub Logo
Followers 145
Posts 27565
Boards Moderated 3
Alias Born 02/07/2004

Re: DewDiligence post# 1285

Thursday, 10/26/2017 2:09:57 PM

Thursday, October 26, 2017 2:09:57 PM

Post# of 1367
KTOV-Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function

#msg-135723422

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.